Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson’s disease

BACKGROUND: Inflammation and oxidative stress are recognized as important contributors to Parkinson’s disease pathogenesis. As such, genetic variability in these pathways could have a role in susceptibility for the disease as well as in the treatment outcome. Dopaminergic treatment is effective in m...

Descripción completa

Detalles Bibliográficos
Autores principales: Redenšek, Sara, Flisar, Dušan, Kojović, Maja, Kramberger, Milica Gregorič, Georgiev, Dejan, Pirtošek, Zvezdan, Trošt, Maja, Dolžan, Vita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393982/
https://www.ncbi.nlm.nih.gov/pubmed/30813952
http://dx.doi.org/10.1186/s12974-019-1439-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393982/
https://www.ncbi.nlm.nih.gov/pubmed/30813952
http://dx.doi.org/10.1186/s12974-019-1439-y

Ejemplares similares